期刊文献+

首次透析患者血浆髓过氧化物酶与血清超敏C反应蛋白水平的变化 被引量:2

Research on MPO and hs-CRP level changes in first time hemodialysis patients
下载PDF
导出
摘要 目的探讨首次血液透析(hemodialysis,HD)患者透析前、透析中、透析后血浆髓过氧化物酶(MPO)和血清超敏C反应蛋白(hs-CRP)水平的变化,分析其可能的原因及意义。方法收集28例首次HD患者透析前、透析中(HD0.5 h)、透析后(HD 3.0 h)血标本各4 ml,其中2 ml置于乙二胺四乙酸抗凝管,2 ml置于普通试管,低温离心后分别收集血浆和血清。分别采用酶联免疫吸附试验(ELISA法)和免疫比浊法检测血浆MPO和血清hs-CRP水平。比较透析前、透析中、透析后MPO和hs-CRP水平的变化。结果透析中与透析前比较MPO水平明显升高(P<0.05),透析后分别与透析前和透析中比较MPO水平无明显变化(P>0.05)。透析过程中hs-CRP水平无显著变化(P>0.05)。结论首次透析可引起患者体内MPO水平一过性升高,但对患者hs-CRP水平无明显影响。提示首次透析引起的一过性MPO升高很可能是由于透析过程中使用的肝素刺激血管壁固化MPO释放引起。 Objective To investigate the level of plasma myeloperoxidase(MPO) and high-sensitivity C reactive protein(hs-CRP) before dialysis,during dialysis and after dialysis of the patients with first time hemodialysis and to analyze the possible causes and significance.Methods Each 4 ml of blood sample before dialysis,during dialysis(HD 0.5 h) and after dialysis(HD 3.0 h) was collected from 28 cases of first time hemodialysis.In 4 ml of blood sample,2 ml was placed in EDTA anticoagulant tubes and the remaining 2 ml was put in ordinary test tube.After low-temperature centrifugation,plasma and serum were collected respectively.Plasma MPO and serum hs-CRP levels were respectively assayed by ELISA and immunonephelometry for comparing the changes before dialysis,duing dialysis and after dialysis.Results Comparing intradialysis with the pre-dialysis,the levels of MPO were significantly increased(P0.05).Comparing post-dialysis with pre-dialysis and intradialysis,the levels of MPO had no significantly change(P0.05).The hs-CRP levels had no significant change during dialysis(P0.05).Conclusions First time dialysis can cause the transient increase of MPO level,but has no apparent influence on the hs-CRP level.This suggests that the transient elevated MPO level is probably caused by the release of blood vessel-wall MPO stimulated by heparin.
出处 《现代医药卫生》 2012年第8期1121-1122,共2页 Journal of Modern Medicine & Health
基金 山东省自然科学基金资助项目(y2007c114)
关键词 肾透析 髓过氧化物酶 C反应蛋白质 血浆 血清 Renal dialysis Peroxidase C-reactive protein Plasma Serum
  • 相关文献

参考文献14

  • 1Herzog CA,Littrell K,Arko C,et al.Clinical characteristics of dialysispatients with acute myocardial infarction in the United States:a collabo-rative project of the United States Renal Data System and the NationalRegistry of Myocardial Infarction[J].Criculation,2007,116(13):1465-1472.
  • 2NedbálkováM,Soucek M.Hypertension in dialysis patients[J].Vnitr Lek,2008,54(9):827-834.
  • 3Gad MZ,El-Mesallamy HO,Sanad EF.hsCRP,sICAM-1 and TAFI inhemodialysis patients:linking inflammation and hypofibrinolysis to car-diovascular events[J].Kidney Blood Press Res,2008,31(6):189-195.
  • 4Puddu P,Cravero E,Puddu GM,et al.Genes and atherosclerosis:at theorigin of the predisposition[J].Int J Clin Pract,2005,59(4):462-472.
  • 5Meuwese MC,Stroes WS,Hazen SL,et al.Serum myeloperoxidase levelsare associated with the future risk of coronary artery disease in apparentlyhealthy individuals[J].J Am Coll Cardiol,2007,50(2):159-165.
  • 6Reeves EP,Nagl M,Godovac-Zimmermann J,et al.Reassessment of themicrobicidal activity of reactive oxygen species and hypochlorous acidwith reference to the phagocytic vacuole of the neutrophil granulocyte[J].Med Microbiol,2003,52(Pt8):643-651.
  • 7Arnhold J.Properties,functions,and secretion of human myeloperoxidase[J].Biochemistry(Mosc),2004,69(1):4-9.
  • 8Grooteman MP,van Tellingen A,van Houte AJ,et al.Hemedialysis in-duced degranulation of polymorphonuclear cells:no correlation betweenmembrane markers and degranulation products[J].Nephron,2000,85(3):267-274.
  • 9Wu CC,Chen JS,Wu WM,et al.Myeloperoxidase serves as a maker ofoxidative stress during single haemodialysis session using two differentbiocompatible dialysis membranes[J].Nephrol Dial Transplant,2005,20(6):1134-1139.
  • 10Borawski J.Myeloperoxidase as a marker of hemodialysis biocompatibil-ity and oxidative stress:the underestimated modifying effects of heparin[J].Am J Kidney Dis,2006,47(1):37-41.

同被引文献18

  • 1许乃芹,卢莹,许玮玮,薛燕.32例慢性肾衰病人首次血液透析焦虑原因分析及干预对策[J].中国实用医药,2007,2(3):69-70. 被引量:6
  • 2章成国,张虹桥,谢坚,邵燕,邢诒刚.缺血性脑血管病与颈动脉粥样硬化的关系[J].中华神经科杂志,2006,39(12):832-835. 被引量:109
  • 3Axelsson J, Bergsten A, Qureshi AR, et al. Elevated resistin levels in chronic kidney disease are associated with decreased glomerular filtram- tion rate and inflammation, but not with insulin resistance[l]. Kidney Int, 2006,69 (3) : 596-604.
  • 4Kaysen GA. The microinflammatory state in uremia:causes and potential consequence[J]. J Am Soe Nephrol, 2011,12 (7) : 1549-1557.
  • 5Taskapan MC,Taskapan H, Sahin I, et al. Serum ieptin, lesistin, and lipid levels in patients with end stage renal failure with regrad to dialysis modality[J]. Ben Fai, 2007,29 ( 2 ) : 147-154.
  • 6Kestenbaum B, Sampson JN, Rudser KD, et al. Serum phosphate levels and mortality risk among people with chronic kidney disease[J]. J Am Soc Nephrol, 2005,16 (2) : 520-528.
  • 7Honda H, Qureshi AR, Heimburger O, et al. Serum albumin, C-reactive protein,interleukin-6,and fetuina as predictors of malnutrition,cardio- vascular disease,and mortality in patients with ESRD[J]. Am J Kidney Dis,2006,47( 1 ) : 139-148.
  • 8Miller DT, Ridker PM, Libby P, et al. Atherosclerosis :the path from ge- nomics to therapeutics[J]. J Am Coil Cardio1,2007,49 (15) : 1589-1599.
  • 9Memoli B, Minutolo R, Bisesti V, et al. Changes of serum albumin and C- reactive protein are related to changes of interleukin-6 release by periph- eral blood mononuclear cells in hemodialysis patients treated with differ- ent membranes[J]. Am J Kidney Dis, 2002,39 (2) : 266-273.
  • 10Panichl V ,Migliori M,De Pletro S,et al. C-reactive protein and inter- leukin-6 levels are related to renal function in predialytic chronicrenal failure[J]. Nephronogy, 2002,91 (4) : 594-600.

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部